Tailored Internet-administrated Treatment of Panic Symptoms - A Randomised Controlled Trial

Depression Clinical Trial

— NOVA III  

Official title:

Tailored Internet-administrated Treatment of Panic Symptoms - A Randomised Controlled Trial

Clinical Trial Details — Status: Unknown status

Administrative data

• NCT number: NCT01296321
• Other study ID #: GA-FAS-2008-1145
• Status: Unknown status
• Phase: N/A
• First received: February 14, 2011
• Last updated: February 15, 2011
• Start date: February 2010
• Est. completion date: April 2011

Study information

• Verified date: February 2011
• Source: Linkoeping University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether tailored internet-administrated CBT is a feasible approach in the treatment of panic symptoms and comorbid anxiety and depressive symptoms.

Recruitment information / eligibility

• Status: Unknown status
• Enrollment: 57
• Est. completion date: April 2011
• Est. primary completion date: April 2011
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• Be between the ages of 18-30 years old or 31-46 years old

• Have reoccurring panic attacks

Exclusion Criteria:

• Suicide prone

• Alcohol addiction

• PTSD

• OCD

• Ongoing psychological treatment

Related Conditions & MeSH terms

• Anxiety Disorders
• Depression

Intervention

Behavioral:
• Tailored Internet-administrated CBT-Treatment
This intervention contains 6-8 text-based self-help modules in which 4 modules are fixed (the first three and the last) and the rest are "prescribed following the diagnostic telephone interview. These modules contain material on panic disorder, social phobia, stress management, assertiveness training, concentration, relaxation among other things.
• Waitlist
Passive waitlist during 8-10 weeks.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Linkoeping University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Panic Disorder Severity Scale (PDSS)	Change from baseline in panic symptoms two weeks post treatment, at six months and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
Secondary	Clinical Outcome in Routine Evaluation - Outcome Measure (CORE-OM)	Change from baseline in anxiety and depressive symptoms two weeks post treatment, at six months and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
Secondary	Beck Anxiety Inventory (BAI)	Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
Secondary	Montgomery Åsberg Depression Rating Scale-Self Rated (MADRS-S)	Change from baseline in depressive symptoms two weeks post treatment, at six months and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
Secondary	Quality of Life Inventory (QOLI)	Change from baseline in quality of life statements two weeks post treatment, at six months and at 12 months post treatment.	Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment